Clinical Medicine
Listando 128 trabajos del autor/autora 39
Lista de trabajos en el área Clinical Medicine
Mentions
1119
Twitter
2
Wikipedia
172
News
4
Policy
Article
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
Gandhi, L.; Rodriguez-Abreu, D.; Gadgeel, S.; Esteban, E.; Felip, E.; De Angelis, F.; Domine, M.; Clingan, P.; Hochmair, M. J.; Powell, S. F.; Cheng, S. Y. -S.; Bischoff, H. G.; Peled, N.; Grossi, F.; Jennens, R. R.; Reck, M.; Hui, R.; Garon, E. B.; Boyer,
NEW ENGLAND JOURNAL OF MEDICINE
0028-4793 (2018)
DOI /
10.1056/nejmoa1801005
Green published, Bronze
Mentions
2771
Twitter
0
Wikipedia
4
News
0
Policy
Article
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
Pinato, David J.; Zambelli, Alberto; Aguilar-Company, Juan; Bower, Mark; Sng, Christopher C. T.; Salazar, Ramon; Bertuzzi, Alexia; Brunet, Joan; Mesia, Ricard; Segui, Elia; Biello, Federica; Generali, Daniele; Grisanti, Salvatore; Rizzo, Gianpiero; Liberti
CANCER DISCOVERY
2159-8274 (2020)
DOI /
10.1158/2159-8290.cd-20-0773
Green published, Bronze
Mentions
479
Twitter
0
Wikipedia
37
News
0
Policy
Article
Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer
Li, Bob T.; Smit, Egbert F.; Goto, Yasushi; Nakagawa, Kazuhiko; Udagawa, Hibiki; Mazieres, Julien; Nagasaka, Misako; Bazhenova, Lyudmila; Saltos, Andreas N.; Felip, Enriqueta; Pacheco, Jose M.; Perol, Maurice; Paz-Ares, Luis; Saxena, Kapil; Shiga, Ryota; C
NEW ENGLAND JOURNAL OF MEDICINE
0028-4793 (2021)
DOI /
10.1056/nejmoa2112431
Mentions
333
Twitter
0
Wikipedia
33
News
1
Policy
Article
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
Carbone, D. P.; Reck, M.; Paz-Ares, L.; Creelan, B.; Horn, L.; Steins, M.; Felip, E.; Van Den Heuvel, M. M.; Ciuleanu, T. -E.; Badin, F.; Ready, N.; Hiltermann, T. J. N.; Nair, S.; Juergens, R.; Peters, S.; Minenza, E.; Wrangle, J. M.; Rodriguez-Abreu, D.;
NEW ENGLAND JOURNAL OF MEDICINE
0028-4793 (2017)
DOI /
10.1056/nejmoa1613493
Green published, Green accepted, Bronze
Mentions
187
Twitter
0
Wikipedia
26
News
0
Policy
Article
Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer
Camidge, D. R.; Kim, H. R.; Ahn, M. -J.; Yang, J. C. -H.; Han, J. -Y.; Lee, J. -S.; Hochmair, M. J.; Li, J. Y. -C.; Chang, G. -C.; Lee, K. H.; Gridelli, C.; Delmonte, A.; Garcia Campelo, R.; Kim, D. -W.; Bearz, A.; Griesinger, F.; Morabito, A.; Felip, E.;
NEW ENGLAND JOURNAL OF MEDICINE
0028-4793 (2018)
DOI /
10.1056/nejmoa1810171
Bronze, Green published
Mentions
166
Twitter
0
Wikipedia
26
News
0
Policy
Article
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer
Shaw, Alice T.; Bauer, Todd M.; de Marinis, Filippo; Felip, Enriqueta; Goto, Yasushi; Liu, Geoffrey; Mazieres, Julien; Kim, Dong-Wan; Mok, Tony; Polli, Anna; Thurm, Holger; Calella, Anna M.; Peltz, Gerson; Solomon, Benjamin J.
NEW ENGLAND JOURNAL OF MEDICINE
0028-4793 (2020)
DOI /
10.1056/nejmoa2027187
Mentions
221
Twitter
0
Wikipedia
17
News
0
Policy
Article
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer
Wolf, Juergen; Seto, Takashi; Han, Ji-Youn; Reguart, Noemi; Garon, Edward B.; Groen, Harry J. M.; Tan, Daniel S. W.; Hida, Toyoaki; de Jonge, Maja; Orlov, Sergey V.; Smit, Egbert F.; Souquet, Pierre-Jean; Vansteenkiste, Johan; Hochmair, Maximilian; Felip,
NEW ENGLAND JOURNAL OF MEDICINE
0028-4793 (2020)
DOI /
10.1056/nejmoa2002787
Mentions
175
Twitter
0
Wikipedia
21
News
0
Policy
Article
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
Felip, Enriqueta; Altorki, Nasser; Zhou, Caicun; Csoszi, Tibor; Vynnychenko, Ihor; Goloborodko, Oleksandr; Luft, Alexander; Akopov, Andrey; Martinez-Marti, Alex; Kenmotsu, Hirotsugu; Chen, Yuh-Min; Chella, Antonio; Sugawara, Shunichi; Voong, David; Wu, Fan
LANCET
0140-6736 (2021)
DOI /
10.1016/s0140-6736(21)02098-5
Mentions
149
Twitter
0
Wikipedia
16
News
3
Policy
Article
Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer
Solomon, Benjamin J.; Kim, Dong-Wan; Wu, Yi-Long; Nakagawa, Kazuhiko; Mekhail, Tarek; Felip, Enriqueta; Cappuzzo, Federico; Paolini, Jolanda; Usari, Tiziana; Tang, Yiyun; Wilner, Keith D.; Blackhall, Fiona; Mok, Tony S.
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2018)
DOI /
10.1200/jco.2017.77.4794
Mentions
124
Twitter
1
Wikipedia
23
News
0
Policy
Article
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC
Herbst, Roy S.; Giaccone, Giuseppe; de Marinis, Filippo; Reinmuth, Niels; Vergnenegre, Alain; Barrios, Carlos H.; Morise, Masahiro; Felip, Enriqueta; Andric, Zoran; Geater, Sarayut; Ozguroglu, Mustafa; Zou, Wei; Sandler, Alan; Enquist, Ida; Komatsubara, Ki
NEW ENGLAND JOURNAL OF MEDICINE
0028-4793 (2020)
DOI /
10.1056/nejmoa1917346
Mentions
144
Twitter
0
Wikipedia
10
News
0
Policy
Article
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial
Paz-Ares, Luis; Ciuleanu, Tudor-Eliade; Cobo, Manuel; Schenker, Michael; Zurawski, Bogdan; Menezes, Juliana; Richardet, Eduardo; Bennouna, Jaafar; Felip, Enriqueta; Juan-Vidal, Oscar; Alexandru, Aurelia; Sakai, Hiroshi; Lingua, Alejo; Salman, Pamela; Souqu
LANCET ONCOLOGY
1470-2045 (2021)
DOI /
10.1016/s1470-2045(20)30641-0
Mentions
94
Twitter
0
Wikipedia
14
News
3
Policy
Article
Five-Year Overall Survival for Patients With Advanced Non-Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
Garon, Edward B.; Hellmann, Matthew D.; Rizvi, Naiyer A.; Carcereny, Enric; Leighl, Natasha B.; Ahn, Myung-Ju; Eder, Joseph Paul; Balmanoukian, Ani S.; Aggarwal, Charu; Horn, Leora; Patnaik, Amita; Gubens, Matthew; Ramalingam, Suresh S.; Felip, Enriqueta;
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2019)
DOI /
10.1200/jco.19.00934
Green published, Gold other
Mentions
87
Twitter
1
Wikipedia
16
News
2
Policy
Article
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Gadgeel, Shirish; Rodriguez-Abreu, Delvys; Speranza, Giovanna; Esteban, Emilio; Felip, Enriqueta; Domine, Manuel; Hui, Rina; Hochmair, Maximilian J.; Clingan, Philip; Powell, Steven F.; Cheng, Susanna Yee-Shan; Bischoff, Helge G.; Peled, Nir; Grossi, Franc
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2020)
DOI /
10.1200/jco.19.03136
Green published
Mentions
102
Twitter
0
Wikipedia
5
News
0
Policy
Article
Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours
Fernandes Neto, Joao M.; Nadal, Ernest; Bosdriesz, Evert; Ooft, Salo N.; Farre, Lourdes; McLean, Chelsea; Klarenbeek, Sjoerd; Jurgens, Anouk; Hagen, Hannes; Wang, Liqin; Felip, Enriqueta; Martinez-Marti, Alex; Vidal, August; Voest, Emile; Wessels, Lodewyk
NATURE COMMUNICATIONS
(2020)
DOI /
10.1038/s41467-020-16952-9
Green submitted, Green published, Gold
Mentions
98
Twitter
0
Wikipedia
4
News
0
Policy
Article
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial
Shaw, Alice T.; Felip, Enriqueta; Bauer, Todd M.; Besse, Benjamin; Navarro, Alejandro; Postel-Vinay, Sophie; Gainor, Justin F.; Johnson, Melissa; Dietrich, Jorg; James, Leonard P.; Clancy, Jill S.; Chen, Joseph; Martini, Jean-Francois; Abbattista, Antonell
LANCET ONCOLOGY
1470-2045 (2017)
DOI /
10.1016/s1470-2045(17)30680-0
Green accepted
Mentions
13
Twitter
0
Wikipedia
13
News
0
Policy
Article
YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib
Garmendia, Irati; Pajares, Maria J.; Hermida-Prado, Francisco; Ajona, Daniel; Bertolo, Cristina; Sainz, Cristina; Lavin, Amaya; Remirez, Ana B.; Valencia, Karmele; Moreno, Haritz; Ferrer, Irene; Behrens, Carmen; Cuadrado, Myriam; Paz-Ares, Luis; Bustelo, X
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
1073-449X (2019)
DOI /
10.1164/rccm.201807-1292oc
Green published
Mentions
97
Twitter
0
Wikipedia
5
News
0
Policy
Article
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer
Borghaei, Hossein; Gettinger, Scott; Vokes, Everett E.; Chow, Laura Q. M.; Burgio, Marco Angelo; Carpeno, Javier de Castro; Pluzanski, Adam; Arrieta, Oscar; Frontera, Osvaldo Aren; Chiari, Rita; Butts, Charles; Wojcik-Tomaszewska, Joanna; Coudert, Bruno; G
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2021)
DOI /
10.1200/jco.20.01605
Gold other
Mentions
94
Twitter
0
Wikipedia
8
News
0
Policy
Article
ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer
Shaw, Alice T.; Solomon, Benjamin J.; Besse, Benjamin; Bauer, Todd M.; Lin, Chia-Chi; Soo, Ross A.; Riely, Gregory J.; Ou, Sai-Hong Ignatius; Clancy, Jill S.; Li, Sherry; Abbattista, Antonello; Thurm, Holger; Satouchi, Miyako; Camidge, D. Ross; Kao, Steven
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2019)
DOI /
10.1200/jco.18.02236
Green published, Gold other
Mentions
25
Twitter
0
Wikipedia
10
News
1
Policy
Article
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
Solomon, Benjamin J.; Besse, Benjamin; Bauer, Todd M.; Felip, Enriqueta; Soo, Ross A.; Camidge, D. Ross; Chiari, Rita; Bearz, Alessandra; Lin, Chia-Chi; Gadgeel, Shirish M.; Riely, Gregory J.; Tan, Eng Huat; Seto, Takashi; James, Leonard P.; Clancy, Jill S
LANCET ONCOLOGY
1470-2045 (2018)
DOI /
10.1016/s1470-2045(18)30649-1
Mentions
151
Twitter
0
Wikipedia
0
News
0
Policy
Article
Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer
Schoenfeld, A. J.; Antonia, S. J.; Awad, M. M.; Felip, E.; Gainor, J.; Gettinger, S. N.; Hodi, F. S.; Johnson, M. L.; Leighl, N. B.; Lovly, C. M.; Mok, T.; Perol, M.; Reck, M.; Solomon, B.; Soria, J. -C.; Tan, D. S. W.; Peters, S.; Hellmann, M. D.
ANNALS OF ONCOLOGY
0923-7534 (2021)
DOI /
10.1016/j.annonc.2021.08.2151
Mentions
4
Twitter
0
Wikipedia
10
News
0
Policy
Article
The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer
Smeltzer, Matthew P.; Wynes, Murry W.; Lantuejoul, Sylvie; Soo, Ross; Ramalingam, Suresh S.; Varella-Garcia, Marileila; Taylor, Meghan Meadows; Richeimer, Kristin; Wood, Kelsey; Howell, Kristen E.; Dalurzo, Mercedes Lilana; Felip, Enriqueta; Hollenbeck, Gi
JOURNAL OF THORACIC ONCOLOGY
1556-0864 (2020)
DOI /
10.1016/j.jtho.2020.05.002
Bronze
Mentions
57
Twitter
0
Wikipedia
6
News
0
Policy
Article
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Han, Ji-Youn; Hochmair, Maximilian J.; Lee, Ki Hyeong; Delmonte, Angelo; Garcia Campelo, Maria Rosario; Kim, Dong-Wan; Griesinger, Frank; Felip, Enriqueta; Califano, Raffaele; Spira, Alexan
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2020)
DOI /
10.1200/jco.20.00505
Gold other
Mentions
145
Twitter
0
Wikipedia
0
News
0
Policy
Article
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
Mezquita, Laura; Auclin, Edouard; Ferrara, Roberto; Charrier, Melinda; Remon, Jordi; Planchard, David; Ponce, Santiago; Paz Ares, Luis; Leroy, Laura; Audigier-Valette, Clarisse; Felip, Enriqueta; Zeron-Medina, Jorge; Garrido, Pilar; Brosseau, Solenn; Zalcm
JAMA ONCOLOGY
2374-2437 (2018)
DOI /
10.1001/jamaoncol.2017.4771
Green published, Bronze
Mentions
76
Twitter
0
Wikipedia
6
News
0
Policy
Article
Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer A Phase 1/2 Open-label Nonrandomized Clinical Trial
Zhou, Caicun; Ramalingam, Suresh S.; Kim, Tae Min; Kim, Sang-We; Yang, James Chih-Hsin; Riely, Gregory J.; Mekhail, Tarek; Nguyen, Danny; Campelo, Maria R. Garcia; Felip, Enriqueta; Vincent, Sylvie; Jin, Shu; Griffin, Celina; Bunn, Veronica; Lin, Jianchang
JAMA ONCOLOGY
2374-2437 (2021)
DOI /
10.1001/jamaoncol.2021.4761
Hybrid, Green published
Mentions
73
Twitter
0
Wikipedia
2
News
0
Policy
Article
Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma
Prat, Aleix; Navarro, Alejandro; Pare, Laia; Reguart, Noemi; Galvan, Patricia; Pascual, Tomas; Martinez, Alex; Nuciforo, Paolo; Comerma, Laura; Alos, Llucia; Pardo, Nuria; Cedres, Susana; Fan, Cheng; Parker, Joel S.; Gaba, Lydia; Victoria, Ivan; Vinolas, N
CANCER RESEARCH
0008-5472 (2017)
DOI /
10.1158/0008-5472.can-16-3556
Bronze
Mentions
118
Twitter
0
Wikipedia
1
News
0
Policy
Article
Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial
Goss, Glenwood D.; Felip, Enriqueta; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Goker, Erdem; Georgoulias, Vassilis; Li, WEI; Guclu, Salih; Isla, Dolores; Min, Young Joo; Morabito, Alessandro; Ardizzoni, Andrea; Gadgeel, Shirish M.; Fue
JAMA ONCOLOGY
2374-2437 (2018)
DOI /
10.1001/jamaoncol.2018.0775
Green published, Bronze
Mentions
170
Twitter
0
Wikipedia
2
News
0
Policy
Article
Efficacy of Vemurafenib in Patients With Non-Small-Cell Lung Cancer With BRAF V600 Mutation: An Open-Label, Single-Arm Cohort of the Histology-Independent VE-BASKET Study
Subbiah, Vivek; Gervais, Radj; Riely, Gregory; Hollebecque, Antoine; Blay, Jean-Yves; Felip, Enriqueta; Schuler, Martin; Goncalves, Anthony; Italiano, Antonio; Keedy, Vicki; Chau, Ian; Puzanov, Igor; Raje, Noopur S.; Meric-Bernstam, Funda; Makrutzki, Marti
JCO PRECISION ONCOLOGY
(2019)
DOI /
10.1200/po.18.00266
Gold other, Green published
Mentions
54
Twitter
0
Wikipedia
4
News
2
Policy
Article
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
Horn, Leora; Spigel, David R.; Vokes, Everett E.; Holgado, Esther; Ready, Neal; Steins, Martin; Poddubskaya, Elena; Borghaei, Hossein; Felip, Enriqueta; Paz-Ares, Luis; Pluzanski, Adam; Reckamp, Karen L.; Burgio, Marco A.; Kohlhaeeufl, Martin; Waterhouse,
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2017)
DOI /
10.1200/jco.2017.74.3062
Green published
Mentions
21
Twitter
0
Wikipedia
6
News
0
Policy
Article
Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival
Lazar, Vladimir; Magidi, Shai; Girard, Nicolas; Savignoni, Alexia; Martini, Jean-Francois; Massimini, Giorgio; Bresson, Catherine; Berger, Raanan; Onn, Amir; Raynaud, Jacques; Wunder, Fanny; Berindan-Neagoe, Ioana; Sekacheva, Marina; Brana, Irene; Taberner
NPJ PRECISION ONCOLOGY
(2021)
DOI /
10.1038/s41698-021-00171-6
Gold DOAJ, Green published
Mentions
29
Twitter
0
Wikipedia
6
News
0
Policy
Article
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH)
Peters, Solange; Gettinger, Scott; Johnson, Melissa L.; Janne, Pasi A.; Garassino, Marina C.; Christoph, Daniel; Toh, Chee Keong; Rizvi, Naiyer A.; Chaft, Jamie E.; Carcereny Costa, Enric; Patel, Jyoti D.; Chow, Laura Q. M.; Koczywas, Marianna; Ho, Cheryl;
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2017)
DOI /
10.1200/jco.2016.71.9476
Green published
Mentions
4
Twitter
0
Wikipedia
8
News
0
Policy
Article
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer
Jacobsen, Kirstine; Bertran-Alamillo, Jordi; Angel Molina, Miguel; Teixido, Cristina; Karachaliou, Niki; Pedersen, Martin Haar; Castellvi, Josep; Garzon, Monica; Codony-Servat, Carles; Codony-Servat, Jordi; Gimenez-Capitan, Ana; Drozdowskyj, Ana; Viteri, S
NATURE COMMUNICATIONS
(2017)
DOI /
10.1038/s41467-017-00450-6
Green published, Gold
Mentions
26
Twitter
0
Wikipedia
3
News
7
Policy
Article
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial
Shaw, Alice T.; Kim, Tae Min; Crino, Lucio; Gridelli, Cesare; Kiura, Katsuyuki; Liu, Geoffrey; Novello, Silvia; Bearz, Alessandra; Gautschi, Oliver; Mok, Tony; Nishio, Makoto; Scagliotti, Giorgio; Spigel, David R.; Deudon, Stephanie; Zheng, Cheng; Pantano,
LANCET ONCOLOGY
1470-2045 (2017)
DOI /
10.1016/s1470-2045(17)30339-x
Mentions
64
Twitter
0
Wikipedia
0
News
0
Policy
Article
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial
Rosell, Rafael; Dafni, Urania; Felip, Enriqueta; Curioni-Fontecedro, Alessandra; Gautschi, Oliver; Peters, Solange; Massuti, Bartomeu; Palmero, Ramon; Ponce Aix, Santiago; Carcereny, Enric; Frueh, Martin; Pless, Miklos; Popat, Sanjay; Kotsakis, Athanasios;
LANCET RESPIRATORY MEDICINE
2213-2600 (2017)
DOI /
10.1016/s2213-2600(17)30129-7
Mentions
52
Twitter
0
Wikipedia
2
News
0
Policy
Article
A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors
Ligero, Marta; Garcia-Ruiz, Alonso; Viaplana, Cristina; Villacampa, Guillermo; Raciti, Maria, V; Landa, Jaid; Matos, Ignacio; Martin-Liberal, Juan; Ochoa-de-Olza, Maria; Hierro, Cinta; Mateo, Joaquin; Gonzalez, Macarena; Morales-Barrera, Rafael; Suarez, Cr
RADIOLOGY
0033-8419 (2021)
DOI /
10.1148/radiol.2021200928
Mentions
94
Twitter
0
Wikipedia
0
News
0
Policy
Article
Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience
Oleas, Diana; Bolufer, Monica; Agraz, Irene; Felip, Enriqueta; Munoz, Eva; Gabaldon, Alejandra; Bury, Roxana; Espinel, Eugenia; Seron, Daniel; Garcia-Carro, Clara; Jose Soler, Maria
CLINICAL KIDNEY JOURNAL
2048-8505 (2021)
DOI /
10.1093/ckj/sfaa008
Gold DOAJ
Mentions
8
Twitter
0
Wikipedia
5
News
0
Policy
Article
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component
Yang, James Chih-Hsin; Ahn, Myung-Ju; Kim, Dong-Wan; Ramalingam, Suresh S.; Sequist, Lecia V.; Su, Wu-Chou; Kim, Sang-We; Kim, Joo-Hang; Planchard, David; Felip, Enriqueta; Blackhall, Fiona; Haggstrom, Daniel; Yoh, Kiyotaka; Novello, Silvia; Gold, Kathryn;
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2017)
DOI /
10.1200/jco.2016.70.3223
Mentions
61
Twitter
0
Wikipedia
1
News
0
Policy
Article
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
Vokes, E. E.; Ready, N.; Felip, E.; Horn, L.; Burgio, M. A.; Antonia, S. J.; Frontera, O. Aren; Gettinger, S.; Holgado, E.; Spigel, D.; Waterhouse, D.; Domine, M.; Garassinoio, M.; Chow, L. Q. M.; Blumenschein, G., Jr.; Barlesi, F.; Coudert, B.; Gainor, J.
ANNALS OF ONCOLOGY
0923-7534 (2018)
DOI /
10.1093/annonc/mdy041
Bronze
Mentions
84
Twitter
0
Wikipedia
0
News
0
Policy
Article
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING Study
Conde, Esther; Hernandez, Susana; Martinez, Rebeca; Angulo, Barbara; De castro, Javier; Collazo-Lorduy, Ana; Jimenez, Beatriz; Muriel, Alfonso; Luis Mate, Jose; Moran, Teresa; Aranda, Ignacio; Massuti, Bartomeu; Rojo, Federico; Domine, Manuel; Sansano, Ire
JOURNAL OF THORACIC ONCOLOGY
1556-0864 (2019)
DOI /
10.1016/j.jtho.2019.07.005
Green published, Gold other
Mentions
77
Twitter
0
Wikipedia
0
News
0
Policy
Article
Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Garrido, P.; Conde, E.; De Castro, J.; Gomez-Roman, J. J.; Felip, E.; Pijuan, L.; Isla, D.; Sanz, J.; Paz-Ares, L.; Lopez-Rios, F.
CLINICAL & TRANSLATIONAL ONCOLOGY
1699-048X (2020)
DOI /
10.1007/s12094-019-02218-4
Gold other, Green published
Mentions
45
Twitter
0
Wikipedia
2
News
0
Policy
Article
CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations
Felip, Enriqueta; Ardizzoni, Andrea; Ciuleanu, Tudor; Cobo, Manuel; Laktionov, Konstantin; Szilasi, Maria; Califano, Raffaele; Carcereny, Enric; Griffiths, Richard; Paz-Ares, Luis; Duchnowska, Renata; Alonso Garcia, Miriam; Isla, Dolores; Jassem, Jacek; Ap
EUROPEAN JOURNAL OF CANCER
0959-8049 (2020)
DOI /
10.1016/j.ejca.2019.11.019
Green published, Gold other
Mentions
60
Twitter
0
Wikipedia
1
News
0
Policy
Article
Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1 positive advanced non small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies
Nosaki, Kaname; Saka, Hideo; Hosomi, Yukio; Baas, Paul; de Castro, Gilberto, Jr.; Reck, Martin; Wu, Yi-Long; Brahmer, Julie R.; Felip, Enriqueta; Sawada, Takeshi; Noguchi, Kazuo; Han, Shi Rong; Piperdi, Bilal; Kush, Debra A.; Lopes, Gilberto
LUNG CANCER
0169-5002 (2019)
DOI /
10.1016/j.lungcan.2019.07.004
Mentions
30
Twitter
0
Wikipedia
4
News
0
Policy
Article
Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer
Wu, Yi-Long; Zhang, LI; Kim, Dong-Wan; Liu, XiaoQing; Lee, Dae Ho; Yang, James Chih-Hsin; Ahn, Myung-Ju; Vansteenkiste, Johan F.; Su, Wu-Chou; Felip, Enriqueta; Chia, Vincent; Glaser, Sabine; Pultar, Philippe; Zhao, Sylvia; Peng, Bin; Akimov, Mikhail; Tan,
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2018)
DOI /
10.1200/jco.2018.77.7326
Green published
Mentions
64
Twitter
0
Wikipedia
0
News
0
Policy
Article
Overcoming EGFR(G724S)-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors
Fassunke, Jana; Mueller, Fabienne; Keul, Marina; Michels, Sebastian; Dammert, Marcel A.; Schmitt, Anna; Plenker, Dennis; Lategahn, Jonas; Heydt, Carina; Braegelmann, Johannes; Tumbrink, Hannah L.; Alber, Yannic; Klein, Sebastian; Heimsoeth, Alena; Dahmen,
NATURE COMMUNICATIONS
(2018)
DOI /
10.1038/s41467-018-07078-0
Gold DOAJ, Green published
Mentions
38
Twitter
0
Wikipedia
2
News
0
Policy
Article
Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial
Hui, R.; Garon, E. B.; Goldman, J. W.; Leighl, N. B.; Hellmann, M. D.; Patnaik, A.; Gandhi, L.; Eder, J. P.; Ahn, M-J; Horn, L.; Felip, E.; Carcereny, E.; Rangwala, R.; Lubiniecki, G. M.; Zhang, J.; Emancipator, K.; Roach, C.; Rizvi, N. A.
ANNALS OF ONCOLOGY
0923-7534 (2017)
DOI /
10.1093/annonc/mdx008
Green published, Bronze
Mentions
30
Twitter
0
Wikipedia
2
News
0
Policy
Article
Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping
Zugazagoitia, J.; Ramos, I.; Trigo, J. M.; Palka, M.; Gomez-Rueda, A.; Jantus-Lewintre, E.; Camps, C.; Isla, D.; Iranzo, P.; Ponce-Aix, S.; Garcia-Campelo, R.; Provencio, M.; Franco, F.; Bernabe, R.; Juan-Vidal, O.; Felip, E.; De Castro, J.; Sanchez-Torres
ANNALS OF ONCOLOGY
0923-7534 (2019)
DOI /
10.1093/annonc/mdy512
Gold other
Mentions
68
Twitter
0
Wikipedia
0
News
0
Policy
Article
Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 Criteria
Matos, Ignacio; Martin-Liberal, Juan; Garcia-Ruiz, Alonso; Hierro, Cinta; Ochoa de Olza, Maria; Viaplana, Cristina; Azaro, Analia; Vieito, Maria; Brana, Irene; Mur, Gemma; Ros, Javier; Mateos, Jose; Villacampa, Guillermo; Berche, Roger; Oliveira, Mafalda;
CLINICAL CANCER RESEARCH
1078-0432 (2020)
DOI /
10.1158/1078-0432.ccr-19-2226
Bronze
Mentions
43
Twitter
0
Wikipedia
0
News
0
Policy
Article
Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials
Dienstmann, Rodrigo; Garralda, Elena; Aguilar, Susana; Sala, Gemma; Viaplana, Cristina; Ruiz-Pace, Fiorella; Gonzalez-Zorelle, Jenifer; Grazia LoGiacco, Deborah; Ogbah, Zighereda; Ramos Masdeu, Laia; Mancuso, Francesco; Fasani, Roberta; Jimenez, Jose; Mart
JCO PRECISION ONCOLOGY
(2020)
DOI /
10.1200/po.19.00398
Gold other, Green published
Mentions
9
Twitter
0
Wikipedia
2
News
0
Policy
Article
Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189
Rodriguez-Abreu, D.; Powell, S. F.; Hochmair, M. J.; Gadgeel, S.; Esteban, E.; Felip, E.; Speranza, G.; De Angelis, F.; Domine, M.; Cheng, S. Y.; Bischoff, H. G.; Peled, N.; Reck, M.; Hui, R.; Garon, E. B.; Boyer, M.; Kurata, T.; Yang, J.; Pietanza, M. C.;
ANNALS OF ONCOLOGY
0923-7534 (2021)
DOI /
10.1016/j.annonc.2021.04.008
Mentions
70
Twitter
0
Wikipedia
0
News
0
Policy
Article
Acute kidney injury as a risk factor for mortality in oncological patients receiving checkpoint inhibitors
Garcia-Carro, Clara; Bolufer, Monica; Bury, Roxana; Cataneda, Zaira; Munoz, Eva; Felip, Enriqueta; Lorente, David; Josep Carreras, Maria; Gabaldon, Alejandra; Agraz, Irene; Seron, Daniel; Jose Soler, Maria
NEPHROLOGY DIALYSIS TRANSPLANTATION
(2021)
DOI /
10.1093/ndt/gfab034
Mentions
2
Twitter
0
Wikipedia
3
News
0
Policy
Article
Evaluation of the VeriStrat (R) serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study
Gadgeel, Shirish; Goss, Glenwood; Soria, Jean-Charles; Felip, Enriqueta; Georgoulias, Vassilis; Lu, Shun; Cobo, Manuel; Syrigos, Konstantinos; Lee, Ki Hyeong; Goker, Erdem; Guclu, Salih Z.; Isla, Dolores; Morabito, Alessandro; Dupuis, Nicholas; Buehnemann,
LUNG CANCER
0169-5002 (2017)
DOI /
10.1016/j.lungcan.2017.05.010
Gold other
Mentions
25
Twitter
0
Wikipedia
0
News
0
Policy
Article
Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer
Frigola, Joan; Navarro, Alejandro; Carbonell, Caterina; Callejo, Ana; Iranzo, Patricia; Cedres, Susana; Martinez-Marti, Alex; Pardo, Nuria; Saoudi-Gonzalez, Nadia; Martinez, Debora; Jimenez, Jose; Sansano, Irene; Mancuso, Francesco M.; Nuciforo, Paolo; Mon
MOLECULAR ONCOLOGY
1574-7891 (2021)
DOI /
10.1002/1878-0261.12891
Gold DOAJ, Green published
Mentions
4
Twitter
0
Wikipedia
3
News
0
Policy
Article
Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey
Garrido, P.; Adjei, A. A.; Bajpai, J.; Banerjee, S.; Berghoff, A. S.; Choo, S. P.; Felip, E.; Furness, A. J. S.; Garralda, E.; Haanen, J.; Letsch, A.; Linardou, H.; Peters, S.; Sessa, C.; Tabernero, J.; Tsang, J.; Yang, J. C-H; Garassino, M. C.
ESMO OPEN
(2021)
DOI /
10.1016/j.esmoop.2021.100131
Gold, Green published
Mentions
26
Twitter
0
Wikipedia
1
News
0
Policy
Article
Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study
Leigh, Natasha B.; Hellmann, Matthew D.; Hui, Rina; Carcereny, Enric; Felip, Enriqueta; Ahn, Myung-Ju; Eder, Joseph Paul; Balmanoukian, Ani S.; Aggarwal, Charu; Horn, Leora; Patnaik, Amita; Gubens, Matthew; Ramalingam, Suresh S.; Lubiniecki, Gregory M.; Zh
LANCET RESPIRATORY MEDICINE
2213-2600 (2019)
DOI /
10.1016/s2213-2600(18)30500-9
Mentions
40
Twitter
0
Wikipedia
0
News
0
Policy
Article
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial
Peters, S.; Felip, E.; Dafni, U.; Belka, C.; Guckenberger, M.; Irigoyen, A.; Nadal, E.; Becker, A.; Vees, H.; Pless, M.; Martinez-Marti, A.; Tufman, A.; Lambrecht, M.; Andratschke, N.; Piguet, A. C.; Kassapian, M.; Roschitzki-Voser, H.; Rabaglio-Poretti, M
LUNG CANCER
0169-5002 (2019)
DOI /
10.1016/j.lungcan.2019.05.001
Mentions
38
Twitter
0
Wikipedia
0
News
0
Policy
Article
Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)
Martinez-Marti, A.; Felip, E.; Matito, J.; Mereu, E.; Navarro, A.; Cedres, S.; Pardo, N.; Martinez de Castro, A.; Remon, J.; Miquel, J. M.; Guillaumet-Adkins, A.; Nadal, E.; Rodriguez-Esteban, G.; Arques, O.; Fasani, R.; Nuciforo, P.; Heyn, H.; Villanueva,
ANNALS OF ONCOLOGY
0923-7534 (2017)
DOI /
10.1093/annonc/mdx396
Gold other, Green published
Mentions
23
Twitter
0
Wikipedia
2
News
0
Policy
Article
Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platfo
Peters, Solange; Felip, Enriqueta; Dafni, Urania; Tufman, Amanda; Guckenberger, Matthias; Alvarez, Ruth; Nadal, Ernest; Becker, Annemarie; Vees, Hansjorg; Pless, Miklos; Martinez-Marti, Alex; Lambrecht, Maarten; Andratschke, Nicolaus; Tsourti, Zoi; Piguet,
JOURNAL OF THORACIC ONCOLOGY
1556-0864 (2021)
DOI /
10.1016/j.jtho.2020.10.129
Bronze
Mentions
39
Twitter
0
Wikipedia
0
News
0
Policy
Article
Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials
Matos, Ignacio; Villacampa, Guillermo; Hierro, Cinta; Martin-Liberal, Juan; Berche, Roger; Pedrola, Anna; Brana, Irene; Azaro, Analia; Vieito, Maria; Saavedra, Omar; Gardeazabal, Itziar; Hernando-Calvo, Alberto; Alonso, Guzman; Galvao, Vladimir; de Olza, M
EUROPEAN JOURNAL OF CANCER
0959-8049 (2021)
DOI /
10.1016/j.ejca.2021.05.040
Hybrid
Mentions
22
Twitter
0
Wikipedia
0
News
0
Policy
Article
Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: a multicentre, open-label, phase 1 study
Tan, Daniel S-W; Leighl, Natasha B.; Riely, Gregory J.; Yang, James C-H; Sequist, Lecia, V; Wolf, Juergen; Seto, Takashi; Felip, Enriqueta; Aix, Santiago P.; Jonnaert, Maud; Pan, Chun; Tan, Eugene Y.; Ko, Jinnie; Moody, Susan E.; Kim, Dong-Wan
LANCET RESPIRATORY MEDICINE
2213-2600 (2020)
DOI /
10.1016/s2213-2600(19)30267-x
Mentions
4
Twitter
0
Wikipedia
2
News
0
Policy
Article
A randomized, open-label, multicenter, phase 3 study to compare the efficacy and safety of eribulin to treatment of physician's choice in patients with advanced non-small cell lung cancer
Katakami, N.; Felip, E.; Spigel, D. R.; Kim, J. -H.; Olivo, M.; Guo, M.; Nokihara, H.; Yang, J. C. -H.; Iannotti, N.; Satouchi, M.; Barlesi, F.
ANNALS OF ONCOLOGY
0923-7534 (2017)
DOI /
10.1093/annonc/mdx284
Green published, Gold other
Mentions
45
Twitter
0
Wikipedia
0
News
0
Policy
Review
New therapeutic approaches to overcoming resistant EGFR exon 20 alterations
Li, Alex M.; Boichard, Amelie; Felip, Enriqueta; Kurzrock, Razelle
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
1040-8428 (2020)
DOI /
10.1016/j.critrevonc.2020.102990
Mentions
6
Twitter
0
Wikipedia
1
News
0
Policy
Article
Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer
Bauer, Todd M.; Shaw, Alice T.; Johnson, Melissa L.; Navarro, Alejandro; Gainor, Justin F.; Thurm, Holger; Pithavala, Yazdi K.; Abbattista, Antonello; Peltz, Gerson; Felip, Enriqueta
TARGETED ONCOLOGY
1776-2596 (2020)
DOI /
10.1007/s11523-020-00702-4
Green published, Gold other
Mentions
33
Twitter
0
Wikipedia
0
News
0
Policy
Article
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer
Passaro, Antonio; Addeo, Alfredo; von Garnier, Christophe; Blackhall, Fiona; Planchard, David; Felip, Enriqueta; Dziadziuszko, Rafal; de Marinis, Filippo; Reck, Martin; Bouchaab, Hasna; Peters, Solange
ESMO OPEN
(2020)
DOI /
10.1136/esmoopen-2020-000820
Green published, Gold
Mentions
26
Twitter
0
Wikipedia
0
News
0
Policy
Article
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-beta and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial
Paz-Ares, Luis; Kim, Tae Min; Vicente, David; Felip, Enriqueta; Lee, Dae Ho; Lee, Ki Hyeong; Lin, Chia-Chi; Jose Flor, Maria; Di Nicola, Massimo; Maria Alvarez, Rosa; Dussault, Isabelle; Helwig, Christoph; Ojalvo, Laureen S.; Gulley, James L.; Cho, Byoung
JOURNAL OF THORACIC ONCOLOGY
1556-0864 (2020)
DOI /
10.1016/j.jtho.2020.03.003
Mentions
2
Twitter
0
Wikipedia
1
News
0
Policy
Article
Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors
Pros, E.; Saigi, M.; Alameda, D.; Gomez-Mariano, G.; Martinez-Delgado, B.; Alburquerque-Bejar, J. J.; Carretero, J.; Tonda, R.; Esteve-Codina, A.; Catala, I; Palmero, R.; Jove, M.; Lazaro, C.; Patino-Garcia, A.; Gil-Bazo, I; Verdura, S.; Teule, A.; Torres-
ANNALS OF ONCOLOGY
0923-7534 (2020)
DOI /
10.1016/j.annonc.2019.09.001
Bronze
Mentions
23
Twitter
0
Wikipedia
0
News
0
Policy
Article
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
Soosaipillai, Gehan; Wu, Anjui; Dettorre, Gino M.; Diamantis, Nikolaos; Chester, John; Moss, Charlotte; Aguilar-Company, Juan; Bower, Mark; Sng, Christopher C. T.; Salazar, Ramon; Brunet, Joan; Jones, Eleanor; Mesia, Ricard; Jackson, Amanda; Mukherjee, Uma
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
1758-8340 (2021)
DOI /
10.1177/17588359211042224
Green published, Gold
Mentions
26
Twitter
0
Wikipedia
0
News
0
Policy
Article
Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung Cancer
Michels, Sebastian; Heydt, Carina; van Veggel, Bianca; Deschler-Baier, Barbara; Pardo, Nuria; Monkhorst, Kim; Ruesseler, Vanessa; Stratmann, Jan; Griesinger, Frank; Steinhauser, Susanne; Kostenko, Anna; Diebold, Joachim; Fassunke, Jana; Fischer, Rieke; Eng
JCO PRECISION ONCOLOGY
(2019)
DOI /
10.1200/po.18.00210
Green published, Gold other
Mentions
2
Twitter
0
Wikipedia
1
News
0
Policy
Article
Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project
Letovanec, Igor; Finn, Stephen; Zygoura, Panagiota; Smyth, Paul; Soltermann, Alex; Bubendorf, Lukas; Speel, Ernst-Jan; Marchetti, Antonio; Nonaka, Daisuke; Monkhorst, Kim; Hager, Henrik; Martorell, Miguel; Sejda, Aleksandra; Cheney, Richard; Hernandez-Losa
JOURNAL OF THORACIC ONCOLOGY
1556-0864 (2018)
DOI /
10.1016/j.jtho.2017.11.117
Bronze, Green published
Mentions
10
Twitter
0
Wikipedia
1
News
0
Policy
Article
Brigatinib Versus Crizotinib in ALK Inhibitor-Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Han, Ji-Youn; Hochmair, Maximilian J.; Lee, Ki Hyeong; Delmonte, Angelo; Campelo, Maria Rosario Garcia; Kim, Dong-Wan; Griesinger, Frank; Felip, Enriqueta; Califano, Raffaele; Spira, Alexan
JOURNAL OF THORACIC ONCOLOGY
1556-0864 (2021)
DOI /
10.1016/j.jtho.2021.07.035
Hybrid
Mentions
27
Twitter
0
Wikipedia
0
News
0
Policy
Article
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial
Herbst, R. S.; Baas, P.; Perez-Gracia, J. L.; Felip, E.; Kim, D. -W.; Han, J. -Y.; Molina, J. R.; Kim, J. -H.; Arvis, C. Dubos; Ahn, M. -J.; Majem, M.; Fidler, M. J.; Surmont, V.; de Castro, G., Jr.; Garrido, M.; Shentu, Y.; Emancipator, K.; Samkari, A.; J
ANNALS OF ONCOLOGY
0923-7534 (2019)
DOI /
10.1093/annonc/mdy545
Green published, Gold other
Mentions
20
Twitter
0
Wikipedia
0
News
0
Policy
Article
CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials
Goss, G.; Tsai, C-M; Shepherd, F. A.; Ahn, M-J; Bazhenova, L.; Crino, L.; De Marinis, F.; Felip, E.; Morabito, A.; Hodge, R.; Cantarini, M.; Johnson, M.; Mitsudomi, T.; Janne, P. A.; Yang, J. C-H
ANNALS OF ONCOLOGY
0923-7534 (2018)
DOI /
10.1093/annonc/mdx820
Bronze
Mentions
27
Twitter
0
Wikipedia
0
News
0
Policy
Article
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update
Reck, M.; Ciuleanu, T. -E.; Cobo, M.; Schenker, M.; Zurawski, B.; Menezes, J.; Richardet, E.; Bennouna, J.; Felip, E.; Juan-Vidal, O.; Alexandru, A.; Sakai, H.; Lingua, A.; Reyes, F.; Souquet, P. -J.; De Marchiy, P.; Martin, C.; Perol, M.; Scherpereel, A.;
ESMO OPEN
(2021)
DOI /
10.1016/j.esmoop.2021.100273
Green published, Gold
Mentions
19
Twitter
0
Wikipedia
0
News
0
Policy
Article
Plain language summary of the CROWN study comparing lorlatinib with crizotinib for people with untreated non-small cell lung cancer
Solomon, Benjamin J.; Bauer, Todd M.; de Marinis, Filippo; Felip, Enriqueta; Goto, Yasushi; Liu, Geoffrey; Mazieres, Julien; Kim, Dong-Wan; Mok, Tony; Polli, Anna; Thurm, Holger; Calella, Anna Maria; Peltz, Gerson; Shaw, Alice T.
FUTURE ONCOLOGY
1479-6694 (2021)
DOI /
10.2217/fon-2021-0904
Hybrid
Mentions
22
Twitter
0
Wikipedia
0
News
0
Policy
Article
Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial
Michels, Sebastian; Massuti, Bartomeu; Schildhaus, Hans-Ulrich; Franklin, Jeremy; Sebastian, Martin; Felip, Enriqueta; Grohe, Christian; Rodriguez-Abreu, Delvys; Abdulla, Diana S. Y.; Bischoff, Helge; Brandts, Christian; Carcereny, Enric; Corral, Jesus; Di
JOURNAL OF THORACIC ONCOLOGY
1556-0864 (2019)
DOI /
10.1016/j.jtho.2019.03.020
Green published, Bronze
Mentions
2
Twitter
0
Wikipedia
1
News
0
Policy
Article
Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC
Jassem, Jacek; de Marinis, Filippo; Giaccone, Giuseppe; Vergnenegre, Alain; Barrios, Carlos H.; Morise, Masahiro; Felip, Enriqueta; Oprean, Cristina; Kim, Young-Chul; Andric, Zoran; Mocci, Simonetta; Enquist, Ida; Komatsubara, Kimberly; McCleland, Mark; Ku
JOURNAL OF THORACIC ONCOLOGY
1556-0864 (2021)
DOI /
10.1016/j.jtho.2021.06.019
Mentions
2
Twitter
0
Wikipedia
1
News
0
Policy
Article
Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
Sequist, Lecia, V; Gray, Jhanelle Elaine; Harb, Wael A.; Lopez-Chavez, Ariel; Doebele, Robert C.; Modiano, Manuel R.; Jackman, David Michael; Baggstrom, Maria Quintos; Atmaca, Akin; Felip, Enriqueta; Provencio, Mariano; Cobo, Manuel; Adiwijaya, Bambang; Ku
ONCOLOGIST
1083-7159 (2019)
DOI /
10.1634/theoncologist.2018-0695
Green published, Bronze
Mentions
18
Twitter
0
Wikipedia
0
News
0
Policy
Article
Interrelations between Patients' Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients
Callejo, Ana; Frigola, Joan; Iranzo, Patricia; Carbonell, Caterina; Diaz, Nely; Marmolejo, David; Assaf, Juan David; Cedres, Susana; Martinez-Marti, Alex; Navarro, Alejandro; Pardo, Nuria; Amat, Ramon; Felip, Enriqueta
CANCERS
(2021)
DOI /
10.3390/cancers13133249
Gold, Green published
Mentions
5
Twitter
0
Wikipedia
0
News
0
Policy
Article
Real-world treatment outcomes with brigatinib in patients with pretreated ALK plus metastatic non-small cell lung cancer
Popat, Sanjay; Brustugun, Odd Terje; Cadranel, Jacques; Felip, Enriqueta; Garassino, Marina Chiara; Griesinger, Frank; Helland, Aslaug; Hochmair, Maximilian; Perol, Maurice; Bent-Ennakhil, Nawal; Kruhl, Christian; Novello, Silvia
LUNG CANCER
0169-5002 (2021)
DOI /
10.1016/j.lungcan.2021.05.017
Green published, Gold other
Mentions
20
Twitter
0
Wikipedia
0
News
0
Policy
Article
Clinical Management of Adverse Events Associated with Lorlatinib
Bauer, Todd M.; Felip, Enriqueta; Solomon, Benjamin J.; Thurm, Holger; Peltz, Gerson; Chioda, Marc D.; Shaw, Alice T.
ONCOLOGIST
1083-7159 (2019)
DOI /
10.1634/theoncologist.2018-0380
Green published, Bronze
Mentions
5
Twitter
0
Wikipedia
0
News
0
Policy
Article
Genetic evolution to tyrosine kinase inhibitory therapy in patients with EGFR-mutated non-small-cell lung cancer
Martinez-Marti, Alex; Felip, Enriqueta; Mancuso, Francesco Mattia; Caratu, Ginevra; Matito, Judit; Nuciforo, Paolo; Sansano, Irene; Diaz-Mejia, Nely; Cedres, Susana; Callejo, Ana; Iranzo, Patricia; Pardo, Nuria; Miquel, Josep Maria; Navarro, Alejandro; Viv
BRITISH JOURNAL OF CANCER
0007-0920 (2021)
DOI /
10.1038/s41416-021-01558-9
Mentions
13
Twitter
0
Wikipedia
0
News
0
Policy
Article
Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1-Expressing NSCLC
Barlesi, Fabrice; Garon, Edward B.; Kim, Dong-Wan; Felip, Enriqueta; Han, Ji-Youn; Kim, Joo-Hang; Ahn, Myung-Ju; Fidler, Mary Jo; Gubens, Matthew A.; de Castro, Gilberto, Jr.; Surmont, Veerle; Li, Qiao; Deitz, Anne C.; Lubiniecki, Gregory M.; Herbst, Roy S
JOURNAL OF THORACIC ONCOLOGY
1556-0864 (2019)
DOI /
10.1016/j.jtho.2019.01.016
Bronze
Mentions
10
Twitter
0
Wikipedia
0
News
0
Policy
Article
Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP)
Dziadziuszko, Rafal; Smit, Egbert F.; Dafni, Urania; Wolf, Juergen; Wasag, Bartosz; Biernat, Wojciech; Finn, Stephen P.; Kammler, Roswitha; Tsourti, Zoi; Rabaglio, Manuela; Ruepp, Barbara; Roschitzki-Voser, Heidi; Stahel, Rolf A.; Felip, Enriqueta; Peters,
JOURNAL OF THORACIC ONCOLOGY
1556-0864 (2019)
DOI /
10.1016/j.jtho.2019.02.017
Bronze
Mentions
9
Twitter
0
Wikipedia
0
News
0
Policy
Article
Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition
Pereira, Carolina; Gimenez-Xavier, Pol; Pros, Eva; Pajares, Maria J.; Moro, Massimo; Gomez, Antonio; Navarro, Alejandro; Condom, Enric; Moran, Sebastian; Gomez-Lopez, Gonzalo; Grana, Osvaldo; Rubio-Camarillo, Miriam; Martinez-Marti, Alex; Yokota, Jun; Carr
CLINICAL CANCER RESEARCH
1078-0432 (2017)
DOI /
10.1158/1078-0432.ccr-16-1946
Mentions
11
Twitter
0
Wikipedia
0
News
0
Policy
Article
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology
Garrido, Pilar; Paz-Ares, Luis; Majem, Margarita; Moran, Teresa; Trigo, Jose Manuel; Bosch-Barrera, Joaquim; Garcia-Campelo, Rosario; Gonzalez-Larriba, Jose Luis; Sanchez-Torres, Jose Miguel; Isla, Dolores; Vinolas, Nuria; Camps, Carlos; Insa, Amelia; Juan
CANCER MEDICINE
2045-7634 (2021)
DOI /
10.1002/cam4.4135
Gold, Green published
Mentions
14
Twitter
0
Wikipedia
0
News
0
Policy
Article
Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non-Small-Cell Lung Cancer
Palmero, Ramon; Taus, Alvaro; Viteri, Santiago; Majem, Margarita; Carcereny, Enric; Garde-Noguera, Javier; Felip, Enriqueta; Nadal, Ernest; Malfettone, Andrea; Sampayo, Miguel; Riva, Francois; Nagy, Rebecca J.; Lanman, Richard B.; Faull, Iris; Dix, Daniel;
JCO PRECISION ONCOLOGY
(2021)
DOI /
10.1200/po.20.00241
Mentions
9
Twitter
0
Wikipedia
0
News
0
Policy
Article
5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging
Martinez-Terroba, Elena; Behrens, Carmen; Agorreta, Jackeline; Monso, Eduard; Millares, Laura; Felip, Enriqueta; Rosell, Rafael; Luis Ramirez, Jose; Remirez, Ana; Torre, Wenceslao; Gil-Bazo, Ignacio; Idoate, Miguel A.; de-Torres, Juan P.; Pio, Ruben; Wistu
THORAX
0040-6376 (2019)
DOI /
10.1136/thoraxjnl-2018-212194
Mentions
6
Twitter
0
Wikipedia
0
News
0
Policy
Article
Future care for long-term cancer survivors: towards a new model
Provencio, M.; Romero, N.; Tabernero, J.; Vera, R.; Baz, D., V; Arraiza, A.; Camps, C.; Felip, E.; Garrido, P.; Gaspar, B.; Llombart, M.; Lopez, A.; Ibanez, V. M.; Olmos, J. M.; Mur, C.; Navarro-Ruiz, A.; Pastor, A.; Peiro, M.; Polo, J.; Rodriguez-Lescure,
CLINICAL & TRANSLATIONAL ONCOLOGY
1699-048X (2021)
DOI /
10.1007/s12094-021-02696-5
Hybrid
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Article
MARIPOSA: phase 3 study of first-line amivantamab plus lazertinib versus osimertinib in EGFR-mutant non-small cell lung cancer
Cho, Byoung Chul; Felip, Enriqueta; Hayashi, Hidetoshi; Thomas, Michael; Lu, Shun; Besse, Benjamin; Sun, Tao; Martinez, Melissa; Sethi, Seema N.; Shreeve, S. Martin; Spira, Alexander, I
FUTURE ONCOLOGY
1479-6694 (2021)
DOI /
10.2217/fon-2021-0923
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Review
Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology
Gridelli, Cesare; Baas, Paul; Barlesi, Fabrice; Ciardiello, Fortunato; Crino, Lucio; Felip, Enriqueta; Gadgeel, Shirish; Papadimitrakopoulou, Vali; Paz-Ares, Luis; Planchard, David; Perol, Maurice; Hanna, Nasser; Sgambato, Assunta; Casaluce, Francesca; de
CLINICAL LUNG CANCER
1525-7304 (2018)
DOI /
10.1016/j.cllc.2017.12.010
Green published
Mentions
7
Twitter
0
Wikipedia
0
News
0
Policy
Article
Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance
Zugazagoitia, Jon; Gomez-Rueda, Ana; Jantus-Lewintre, Eloisa; Isla, Dolores; Camps, Carlos; Ramos, Inmaculada; Manuel Trigo, Jose; Bernabe, Reyes; Juan-Vidal, Oscar; Miguel Sanchez-Torres, Jose; Garcia-Campelo, Rosario; Provencio, Mariano; Felip, Enriqueta
LUNG CANCER
0169-5002 (2019)
DOI /
10.1016/j.lungcan.2019.05.032
Mentions
6
Twitter
0
Wikipedia
0
News
0
Policy
Article
Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study
Park, Keunchil; Janne, Pasi A.; Kim, Dong-Wan; Han, Ji-Youn; Wu, Ming-Fang; Lee, Jong-Seok; Kang, Jin-Hyoung; Lee, Dae Ho; Cho, Byoung Chul; Yu, Chong-Jen; Pang, Yong Kek; Felip, Enriqueta; Kim, HyunJin; Baek, Eunhye; Noh, Young Su
CANCER
0008-543X (2021)
DOI /
10.1002/cncr.33385
Gold other
Mentions
5
Twitter
0
Wikipedia
0
News
0
Policy
Article
Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts
Frueh, M.; Panje, C. M.; Reck, M.; Blackhall, F.; Califano, R.; Cappuzzo, F.; Besse, B.; Novello, S.; Garrido, P.; Felip, E.; O'Brien, M.; Ares, L. Paz; De Marinis, F.; Westeel, V; De Ruysscher, D.; Putora, P. M.
LUNG CANCER
0169-5002 (2020)
DOI /
10.1016/j.lungcan.2020.03.024
Mentions
10
Twitter
0
Wikipedia
0
News
0
Policy
Article
Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer
Peters, Solange; Shaw, Alice T.; Besse, Benjamin; Felip, Enriqueta; Solomon, Benjamin J.; Soo, Ross A.; Bearz, Alessandra; Gadgeel, Shirish M.; Lin, Chia-Chi; Kao, Steven; Seto, Takashi; Masters, Elizabeth T.; Abbattista, Antonello; Clancy, Jill S.; Thurm,
LUNG CANCER
0169-5002 (2020)
DOI /
10.1016/j.lungcan.2020.02.011
Mentions
12
Twitter
0
Wikipedia
0
News
0
Policy
Article
Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer
Gerber, David E.; Infante, Jeffrey R.; Gordon, Michael S.; Goldberg, Sarah B.; Martin, Miguel; Felip, Enriqueta; Martinez Garcia, Maria; Schiller, Joan H.; Spigel, David R.; Cordova, Julie; Westcott, Valerie; Wang, Yulei; Shames, David S.; Choi, YounJeong;
CLINICAL CANCER RESEARCH
1078-0432 (2020)
DOI /
10.1158/1078-0432.ccr-18-3965
Mentions
11
Twitter
0
Wikipedia
0
News
0
Policy
Article
Encorafenib plus binimetinib in patients with BRAF(V)(600)-mutant non-small cell lung cancer: Phase II PHAROS study design
Riely, Gregory J.; Ahn, Myung-Ju; Felip, Enriqueta; Ramalingam, Suresh S.; Smit, Egbert F.; Tsao, Anne S.; Alcasid, Ann; Usari, Tiziana; Wissel, Paul S.; Wilner, Keith D.; Johnson, Bruce E.
FUTURE ONCOLOGY
1479-6694 (2021)
DOI /
10.2217/fon-2021-1250
Hybrid
Mentions
7
Twitter
0
Wikipedia
0
News
0
Policy
Article
Medical oncology future plan of the Spanish Society of Medical Oncology: challenges and future needs of the Spanish oncologists
Rivera, F.; Andres, R.; Felip, E.; Garcia-Campelo, R.; Lianes, P.; Llombart, A.; Piera, J. M.; Puente, J.; Rodriguez, C. A.; Vera, R.; Virizuela, J. A.; Martin, M.; Garrido, P.
CLINICAL & TRANSLATIONAL ONCOLOGY
1699-048X (2017)
DOI /
10.1007/s12094-016-1595-9
Green published, Gold other
Mentions
7
Twitter
0
Wikipedia
0
News
0
Policy
Article
Identifying and preventing burnout in young oncologists, an overwhelming challenge in the COVID-19 era: a study of the Spanish Society of Medical Oncology (SEOM)
Jimenez-Labaig, P.; Pacheco-Barcia, V.; Cebria, A.; Galvez, F.; Obispo, B.; Paez, D.; Quilez, A.; Quintanar, T.; Ramchandani, A.; Remon, J.; Rogado, J.; Sanchez, D. A.; Sanchez-Canovas, M.; Sanz-Garcia, E.; Sesma, A.; Tarazona, N.; Cotes, A.; Gonzalez, E.;
ESMO OPEN
(2021)
DOI /
10.1016/j.esmoop.2021.100215
Green published, Gold
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Article
Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non-Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study
Felip, Enriqueta; De Braud, Filippo G.; Maur, Michela; Loong, Herbert H.; Shaw, Alice Tsang; Vansteenkiste, Johan F.; John, Thomas; Liu, Geoffrey; Lolkema, Martijn P.; Selvaggi, Giovanni; Giannone, Vanessa; Cazorla, Pilar; Baum, Jason; Balbin, O. Alejandro
JOURNAL OF THORACIC ONCOLOGY
1556-0864 (2020)
DOI /
10.1016/j.jtho.2019.10.006
Green published, Gold other
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Article
Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database
Remon, J.; Isla, D.; Garrido, P.; De Castro, J.; Majem, M.; Vinolas, N.; Artal, A.; Carcereny, E.; Garcia-Campelo, M. R.; Lianes, P.; Provencio, M.; Juan, O.; Diz, P.; Blanco, R.; Lopez-Castro, R.; Maestu, I.; Vadell, C.; Felip, E.
CLINICAL & TRANSLATIONAL ONCOLOGY
1699-048X (2017)
DOI /
10.1007/s12094-017-1700-8
Mentions
5
Twitter
0
Wikipedia
0
News
0
Policy
Article
Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain
Rodriguez-Lescure, A.; de la Pena, F. A.; Aranda, E.; Calvo, A.; Felip, E.; Garrido, P.; Vera, R.
CLINICAL & TRANSLATIONAL ONCOLOGY
1699-048X (2020)
DOI /
10.1007/s12094-020-02366-y
Gold other, Green published
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Review
Immune-checkpoint inhibition in first-line treatment of advanced non-small cell lung cancer patients: Current status and future approaches
Remon, J.; Pardo, N.; Martinez-Marti, A.; Cedres, S.; Navarro, A.; Martinez de Castro, A. M.; Felip, E.
LUNG CANCER
0169-5002 (2017)
DOI /
10.1016/j.lungcan.2017.02.002
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Review
Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients
Remon, J.; Steuer, C. E.; Ramalingam, S. S.; Felip, E.
ANNALS OF ONCOLOGY
0923-7534 (2018)
DOI /
10.1093/annonc/mdx704
Bronze
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Article
Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF Trial
Molina-Vila, Miguel-Angel; Stahel, Rolf A.; Dafni, Urania; Jordana-Ariza, Nuria; Balada-Bel, Ariadna; Garzon-Ibanez, Monica; Garcia-Pelaez, Beatriz; Mayo-de-las-Casas, Clara; Felip, Enriqueta; Fontecedro, Alessandra Curioni; Gautschi, Oliver; Peters, Solan
JOURNAL OF THORACIC ONCOLOGY
1556-0864 (2020)
DOI /
10.1016/j.jtho.2019.11.023
Bronze
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Article
Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC
Nishio, Makoto; Felip, Enriqueta; Orlov, Sergey; Park, Keunchil; Yu, Chong-Jen; Tsai, Chun-Ming; Cobo, Manuel; McKeage, Mark; Su, Wu-Chou; Mok, Tony; Scagliotti, Giorgio V.; Spigel, David R.; Viraswami-Appanna, Kalyanee; Chen, Zhe; Passos, Vanessa Q.; Shaw
JOURNAL OF THORACIC ONCOLOGY
1556-0864 (2020)
DOI /
10.1016/j.jtho.2019.11.006
Gold other, Green published
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Review
A consensus statement on the gender perspective in lung cancer
Isla, D.; Majem, M.; Vinolas, N.; Artal, A.; Blasco, A.; Felip, E.; Garrido, P.; Remon, J.; Baquedano, M.; Borras, J. M.; Die Trill, M.; Garcia-Campelo, R.; Juan, O.; Leon, C.; Lianes, P.; Lopez-Rios, F.; Molins, L.; Planchuelo, M. A.; Cobo, M.; Paz-Ares,
CLINICAL & TRANSLATIONAL ONCOLOGY
1699-048X (2017)
DOI /
10.1007/s12094-016-1578-x
Green accepted
Mentions
6
Twitter
0
Wikipedia
0
News
0
Policy
Article
Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity
Meulendijks, Didier; Jacob, Wolfgang; Voest, Emile E.; Mau-Sorensen, Morten; Martinez-Garcia, Maria; Taus, Alvaro; Fleitas, Tania; Cervantes, Andres; Lolkema, Martijn P.; Langenberg, Marlies H. G.; de Jonge, Maja J.; Sleijfer, Stefan; Han, Ji-Youn; Calles,
CLINICAL CANCER RESEARCH
1078-0432 (2017)
DOI /
10.1158/1078-0432.ccr-17-0812
Bronze
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Editorial Material
HIV-Positive Patients with Lung Cancer: Is Immunotherapy a Safe and Active Option for Them?
Navarro, Alejandro; Martinez-Marti, Alex; Felip, Enriqueta
JOURNAL OF THORACIC ONCOLOGY
1556-0864 (2018)
DOI /
10.1016/j.jtho.2018.05.005
Bronze
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Article
Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs
Felip, E.; Shaw, A. T.; Bearz, A.; Camidge, D. R.; Solomon, B. J.; Bauman, J. R.; Bauer, T. M.; Peters, S.; Toffalorio, F.; Abbattista, A.; Thurm, H.; Peltz, G.; Wiltshire, R.; Besse, B.
ANNALS OF ONCOLOGY
0923-7534 (2021)
DOI /
10.1016/j.annonc.2021.02.012
Gold other
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Review
The accelerated path of ceritinib: Translating pre-clinical development into clinical efficacy
Mok, Tony S. K.; Crino, Lucio; Felip, Enriqueta; Salgia, Ravi; De Pas, Tommaso; Tan, Daniel S. W.; Chow, Laura Q. M.
CANCER TREATMENT REVIEWS
0305-7372 (2017)
DOI /
10.1016/j.ctrv.2017.03.006
Gold other, Green accepted
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung Cancer
Felip, Enriqueta; Barlesi, Fabrice; Besse, Benjamin; Chu, Quincy; Gandhi, Leena; Kim, Sang-We; Carcereny, Enric; Sequist, Lecia V.; Brunsvig, Paal; Chouaid, Christos; Smit, Egbert F.; Groen, Harry J. M.; Kim, Dong-Wan; Park, Keunchil; Avsar, Emin; Szpakows
JOURNAL OF THORACIC ONCOLOGY
1556-0864 (2018)
DOI /
10.1016/j.jtho.2017.11.131
Bronze
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Article
Safety and clinical activity of atezolizumab monotherapy in metastatic non-small-cell lung cancer: final results from a phase I study
Horn, Leora; Gettinger, Scott N.; Gordon, Michael S.; Herbst, Roy S.; Gandhi, Leena; Felip, Enriqueta; Sequist, Lecia V.; Spigel, David R.; Antonia, Scott J.; Balmanoukian, Ani; Cassier, Philippe A.; Liu, BO; Kowanetz, Marcin; O'Hear, Carol; Fasso, Marcell
EUROPEAN JOURNAL OF CANCER
0959-8049 (2018)
DOI /
10.1016/j.ejca.2018.06.031
Mentions
5
Twitter
0
Wikipedia
0
News
0
Policy
Article
A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer
Cejalvo, Juan-Miguel; Jacob, Wolfgang; Kanonnikoff, Tania Fleitas; Felip, Enriqueta; Navarro Mendivil, Alejandro; Martinez Garcia, Maria; Garcia, Alvaro Taus; Leighl, Natasha; Lassen, Ulrik; Mau-Soerensen, Morten; Adessi, Celine; Michielin, Francesca; Jame
ESMO OPEN
(2019)
DOI /
10.1136/esmoopen-2019-000532
Gold DOAJ, Green published
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Letter
Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient
Domingues, I.; Cedres, S.; Callejo, A.; Vivancos, A.; Martinez-Marti, A.; Felip, E.
PULMONOLOGY
2531-0437 (2020)
DOI /
10.1016/j.pulmoe.2019.05.002
Gold DOAJ
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM)
Elez, E.; Ayala, F.; Felip, E.; Garcia Campelo, R.; Garcia Carbonero, R.; Garcia Donas, J.; Gonzalez Del Alba, A.; Gonzalez Flores, E.; Hidalgo, J.; Isla, D.; Majem, M.; Rodriguez Lescure, A.; Safont, M. J.; Santaballa, A.; Villacampa, G.; Vera, R.; Garrid
ESMO OPEN
(2021)
DOI /
10.1016/j.esmoop.2021.100048
Gold DOAJ, Green published
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation
Cedres, Susana; Felip, Enriqueta; Cruz, Cristina; Martinez de Castro, Ana; Pardo, Nuria; Navarro, Alejandro; Martinez-Marti, Alex; Remon, Jordin; Zeron-Medina, Jorge; Balmana, Judith; Llop-Guevara, Alba; Miquel, Josep M.; Sansano, Irene; Nuciforo, Paolo; M
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
0027-8874 (2018)
DOI /
10.1093/jnci/djy012
Gold other, Green published
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Review
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping
Salgia, Ravi; Sattler, Martin; Scheele, Juergen; Stroh, Christopher; Felip, Enriqueta
CANCER TREATMENT REVIEWS
0305-7372 (2020)
DOI /
10.1016/j.ctrv.2020.102022
Gold other
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Editorial Material
Pembrolizumab in advanced pretreated small cell lung cancer patients with PD-L1 expression: data from the KEYNOTE-028 trial: a reason for hope?
Navarro, Alejandro; Felip, Enriqueta
TRANSLATIONAL LUNG CANCER RESEARCH
2218-6751 (2017)
DOI /
10.21037/tlcr.2017.10.04
Green published
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
Analysis of mismatch repair (MMR) proteins expression in a series of malignant pleural mesothelioma (MPM) patients
Cedres, S.; Ponce-Aix, S.; Iranzo, P.; Callejo, A.; Pardo, N.; Navarro, A.; Martinez-Marti, A.; Gomez-Abecia, S.; Zucchiatti, A. C.; Enguita, A. B.; Miquel, J. M.; Viaplana, C.; Dienstmann, R.; Paz-Ares, L.; Felip, E.
CLINICAL & TRANSLATIONAL ONCOLOGY
1699-048X (2020)
DOI /
10.1007/s12094-019-02275-9
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
Cedres, Susana; Assaf, Juan-David; Iranzo, Patricia; Callejo, Ana; Pardo, Nuria; Navarro, Alejandro; Martinez-Marti, Alex; Marmolejo, David; Rezqallah, Alejandra; Carbonell, Caterina; Frigola, Joan; Amat, Ramon; Pedrola, Anna; Dienstmann, Rodrigo; Felip, E
SCIENTIFIC REPORTS
2045-2322 (2021)
DOI /
10.1038/s41598-021-00831-4
Gold
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Editorial Material
Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol
Levy, Benjamin; Paz-Ares, Luis; Bennouna, Jaafar; Felip, Enriqueta; Rodriguez Abreu, Delvys; Isla, Dolores; Barlesi, Fabrice; Molinier, Olivier; Madelaine, Jeannick; Audigier-Valette, Clarisse; Kim, Sang-We; Kim, Hye Ryun; Ozguroglu, Mustafa; Erman, Mustaf
CLINICAL LUNG CANCER
1525-7304 (2019)
DOI /
10.1016/j.cllc.2018.12.022
Gold other
Mentions
0
Twitter
0
Wikipedia
0
News
0
Policy
Article
An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer
Morgensztern, Daniel; Karaseva, Nina; Felip, Enriqueta; Delgado, Ignacio; Burdaeva, Olga; Domine, Manuel; Lara, Primo; Paik, Paul K.; Lassen, Ulrik; Orlov, Sergey; Trigo, Jose; Shomova, Marina; Baker-Neblett, Katherine; Vasquez, James; Wang, Xiaowei; Yan,
LUNG CANCER
0169-5002 (2019)
DOI /
10.1016/j.lungcan.2019.08.011
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy
Felip, Enriqueta; Hirsh, Vera; Popat, Sanjay; Cobo, Manuel; Fulop, Andrea; Dayen, Charles; Trigo, Jose M.; Gregg, Richard; Waller, Cornelius F.; Soria, Jean-Charles; Goss, Glenwood D.; Gordon, James; Wang, Bushi; Palmer, Michael; Ehrnrooth, Eva; Gadgeel, S
CLINICAL LUNG CANCER
1525-7304 (2018)
DOI /
10.1016/j.cllc.2017.06.002
Gold other, Green published
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Review
Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors
Nadal, Ernest; Massuti, Bartomeu; Domine, Manuel; Garcia-Campelo, Rosario; Cobo, Manuel; Felip, Enriqueta
CANCER IMMUNOLOGY IMMUNOTHERAPY
0340-7004 (2019)
DOI /
10.1007/s00262-019-02310-2
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
Lung Cancer in Never-Smoking Women: A Sub-Analysis of the Spanish Female-Specific Database WORLD07
Vinolas, Nuria; Garrido, Pilar; Isla, Dolores; Provencio, Mariano; Majem, Margarita; Artal, Angel; Carcereny, Enric; Garcia Campelo, Rosario; Lianes, Pilar; De La Penas, Ramon; Felip, Enriqueta
CANCER INVESTIGATION
0735-7907 (2017)
DOI /
10.1080/07357907.2017.1295461
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Article
Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus
Isla, D.; De Castro, J.; Garcia-Campelo, R.; Lianes, P.; Felip, E.; Garrido, P.; Paz-Ares, L.; Trigo, J. M.
CLINICAL & TRANSLATIONAL ONCOLOGY
1699-048X (2020)
DOI /
10.1007/s12094-019-02191-y
Gold other
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer
Levy, Benjamin P.; Giaccone, Giuseppe; Besse, Benjamin; Felip, Enriqueta; Garassino, Marina Chiara; Domine Gomez, Manuel; Garrido, Pilar; Piperdi, Bilal; Ponce-Aix, Santiago; Menezes, Daniel; MacBeth, Kyle J.; Risueno, Alberto; Slepetis, Ruta; Wu, Xiaoling
EUROPEAN JOURNAL OF CANCER
0959-8049 (2019)
DOI /
10.1016/j.ejca.2018.11.028
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Article
Lung cancer in Spanish women: The WORLD07 project
Garrido, Pilar; Vinolas, Nuria; Isla, Dolores; Provencio, Mariano; Majem, Margarita; Artal, Angel; Carcereny, Enric; Garcia Campelo, Rosario; Lianes, Pilar; De La Penas, Ramon; Felip, Enriqueta
EUROPEAN JOURNAL OF CANCER CARE
0961-5423 (2019)
DOI /
10.1111/ecc.12941
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-beta and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort
Tan, Benjamin; Khattak, Adnan; Felip, Enriqueta; Kelly, Karen; Rich, Patricia; Wang, Ding; Helwig, Christoph; Dussault, Isabelle; Ojalvo, Laureen S.; Isambert, Nicolas
TARGETED ONCOLOGY
1776-2596 (2021)
DOI /
10.1007/s11523-021-00809-2
Gold other
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Article
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial
Goss, Glenwood D.; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Goker, Erdem; Georgoulias, Vassilis; Isla, Dolores; Morabito, Alessandro; Min, Young J.; Ardizzoni, Andrea; Bender, Shaun; Cseh, Agnieszka; Felip, Enriqueta
ECLINICALMEDICINE
(2021)
DOI /
10.1016/j.eclinm.2021.100940
Gold, Green published
